Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225
NorthStar to provide Cellectar with non-carrier-added Ac-225 for its expanded portfolio of clinical programs FLORHAM PARK, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: CLRB) a late-stage clinical ...
Business Insider3d
Mestag Therapeutics Expands Leadership Team and Appoints Head of Development and General Counsel
“As we approach our first clinical trial initiation, Jan’s experience across all stages of preclinical and ... has a promising pipeline of drug candidates and the RAFT platform fuelling new ...
TMCnet3d
Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of ...
Business Insider8d
Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
In addition, Mural presented preclinical data from its interleukin (IL ... scope and duration of development activities; the U.S. Food and Drug Administration may make adverse decisions regarding the ...
FierceBiotech3d
Roche teams up with transcription factor trailblazer Flare in new $1.8B-plus cancer pact
Since the 2023 financing round, Flare’s lead program FX-909 has moved into a phase 1 clinical trial for patients with ...
Finanznachrichten2d
Mestag Therapeutics Ltd.: Mestag Therapeutics Expands Leadership Team and Appoints Head of Development and General Counsel
"As we approach our first clinical trial initiation, Jan's experience across all stages of preclinical and ... has a promising pipeline of drug candidates and the RAFT platform fuelling new ...
Allakos Runs Up Into A Near-Term Catalyst
Allakos shifted focus to AK006 in 2024 after lirentelimab's failure in phase 2 trials for atopic dermatitis and CSU. Read why ...
Lonza's Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies Collaboration underscores ...
manilatimes8d
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma
About MB-109 (MB-101 (IL13Rα2 targeted CAR-T cells) + MB-108 oncolytic virus) ...
Hosted on MSN2d
OmniAb, Inc. (NASDAQ:OABI) Q3 2024 Earnings Call Transcript
As our partner's clinical stage programs advance, we're also gaining better insights into timing around key inflection points ...
Actuate to Participate in Lantern’s Pharma Webinar on AI-Driven Drug Development
Companies will discuss how Lantern’s AI platform is being leveraged for the identification and development of enrichment ...
Fractyl Health, Inc. Common Stock (NASDAQ:GUTS) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good afternoon, and welcome to Fractyl Health’s Third Quarter Financial Results and Business Updates Call. As a reminder, this conference ...